Tight blood sugar control for pediatric cardiac surgery patients does not improve outcomes

September 10, 2012 in Cardiology

Tight blood sugar control in the intensive care unit for pediatric cardiac surgery patients does not improve patients' infection rate, mortality, length of stay or organ failure when compared to standard care, new research shows.

The research, conducted at the University of Michigan's C.S. Mott Children's Hospital and Boston Children's Hospital, will be published Online First in the Sept. 7.

"Post-operative complications for infants and young children who have cardiac surgery remains common, so we want to identify risk factors that we can modify and interventions to help speed their recovery," says Michael G. Gaies, M.D., M.P.H., a physician in the Unit at C.S. Mott, and senior author of the study.

"Tight glycemic control using insulin was shown, in some studies, to improve outcomes in adult cardiac surgery patients, but we didn't know whether children would experience similar benefits."

The researchers studied 980 children from newborn to three years old who were undergoing surgery with cardiopulmonary bypass, representing the largest clinical trial ever performed in pediatric cardiac surgical patients. Patients either received standard cardiac intensive care or tight glycemic control using insulin to target blood glucose at a normal level.

"We found no benefits of tight glycemic control, but the reasons are unclear," says Gaies.

Gaies says that routine control of in pediatric cardiac intensive care units has been controversial because of the contradictory results in adult patients and also concerns about the effects of insulin-induced hypoglycemia on the developing brain.

"This study seems to indicate that tight glycemic control should not be standard practice in units for children who have had cardiac surgery," says Gaies. "We will continue investigating new approaches to improve both short-term recovery and longer-term outcomes for children who need cardiac surgery."

More information: doi: 10.1056/NEJMoa1206044

Journal reference: New England Journal of Medicine search and more info website

Provided by University of Michigan Health System search and more info website

not rated yet  

Rank not rated yet
Relevant PhysicsForums posts

More news stories

Costs to treat stroke in America may double by 2030

Costs to treat stroke are projected to more than double and the number of people having strokes may increase 20 percent by 2030, according to the American Heart Association/American Stroke Association.

Cardiology created 11 hours ago | popularity not rated yet | comments 0

New blood-thinner measures may cut medication errors

Blood thinners are the preferred treatment option to prevent heart attacks, blood clots and stroke, but they are not without risk, and not just because of their side effects. These high-risk drugs, known as anticoagulants, ...

Cardiology created 14 hours ago | popularity not rated yet | comments 0

Registry questions superiority of bivalirudin over heparin

Results from a large observational study reported at EuroPCR 2013 today question whether bivalirudin is superior to heparin in the absence of GPIIb/IIIa blockade, showing similar 30-day mortality in patients with non-ST segment ...

Cardiology created 14 hours ago | popularity not rated yet | comments 0

Study shows low rate of late lumen loss with bioresorbable DESolve device

The DESolve bioresorbable coronary scaffold system achieves good efficacy and safety with low rates of late lumen loss and major coronary adverse events at six months, show first results from the pivotal DESolve Nx trial ...

Cardiology created 14 hours ago | popularity not rated yet | comments 0

Biodegradable stent proves non-inferior to drug-eluting stent

The Orsiro stent, which is a novel stent platform eluting sirolimus from a biodegradable polymer, demonstrated non-inferiority to the Xience Prime everolimus-eluting stent for the primary angiographic endpoint of in-stent ...

Cardiology created May 21, 2013 | popularity 5 / 5 (1) | comments 0


Slowing the aging process—only with antibiotics

Swiss scientists reveal the mechanism responsible for aging hidden deep within mitochondria—and dramatically slow it down in worms by administering antibiotics to the young.

Researchers complete largest genetic sequencing study of human disease

Researchers from Queen Mary, University of London have led the largest sequencing study of human disease to date, investigating the genetic basis of six autoimmune diseases.

Brain can be trained in compassion, study shows

Until now, little was scientifically known about the human potential to cultivate compassion—the emotional state of caring for people who are suffering in a way that motivates altruistic behavior.

Having both migraines, depression may mean smaller brain

(HealthDay)—Migraines and depression can each cause a great deal of suffering, but new research indicates the combination of the two may be linked to something else entirely—a smaller brain.

Novel approach for influenza vaccination shows promise in early animal testing

A new approach for immunizing against influenza elicited a more potent immune response and broader protection than the currently licensed seasonal influenza vaccines when tested in mice and ferrets. The vaccine ...

Enzyme-activating antibodies revealed as marker for most severe form of rheumatoid arthritis

In a series of lab experiments designed to unravel the workings of a key enzyme widely considered a possible trigger of rheumatoid arthritis, researchers at Johns Hopkins have found that in the most severe ...